F.D.A. Rejects Closely Watched Lung Cancer Drug From China
OMEGAZEPRIME News
This story was selected and curated by our editorial team in the Biotechnology and Bioengineering category. Published on November 15, 2026 • Originally reported by Rebecca Robbins. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
This story was selected and curated by our editorial team in the Biotechnology and Bioengineering category. Published on November 15, 2026 • Originally reported by Rebecca Robbins. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com